发明名称 |
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) |
摘要 |
The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells. |
申请公布号 |
US9453074(B2) |
申请公布日期 |
2016.09.27 |
申请号 |
US201414254206 |
申请日期 |
2014.04.16 |
申请人 |
Baylor Research Institute |
发明人 |
Oh Sangkon;Li Dapeng |
分类号 |
A61K39/00;A61K39/395;A01N63/00;C07K16/28;A61K47/48;A61K51/10;C07K14/005;C07K14/195;C07K14/37;C07K14/405;C07K14/435 |
主分类号 |
A61K39/00 |
代理机构 |
Norton Rose Fulbright US LLP |
代理人 |
Norton Rose Fulbright US LLP |
主权项 |
1. A method for increasing the effectiveness of antigen presentation by dendritic cells in an individual comprising the steps of:
attaching ex vivo a dendritic cell asialoglycoprotein receptor (DC-ASGPR)-specific antibody or DC-ASGPR-specific fragment thereof to an antigen to form an antibody-antigen complex, wherein the antigen is an autoantigen; and delivering an effective amount of the complex to the individual, wherein the antigen is processed and presented by a dendritic cell that has been contacted with the antibody-antigen complex, wherein the antibody or fragment thereof comprises an immunoglobulin heavy chain selected from the group consisting of SEQ ID NO: 5, 7, 9, or 11, wherein the antibody or fragment thereof targets a human DC-ASGPR. |
地址 |
Dallas TX US |